Mortality Risk Associated with Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled Trials

Keyphrases

• Long-acting Injectable Antipsychotics 100%
• Long-acting Injectable 100%
• Mortality Risk 100%
• Meta-analysis of Randomized Controlled Trials 100%
• Systematic Meta-analysis 100%
• Oral Antipsychotics 35%
• Risk Ratio 35%
• All-cause Mortality 29%
• Suicide 23%
• Olanzapine 11%
• Paliperidone 11%
• Head-to-head Comparison 11%
• Aripiprazole 11%
• Fluphenazine 11%
• Randomized Controlled Trial 11%
• Risperidone 11%
• Patients with Schizophrenia 5%
• Haloperidol 5%
• Zuclopenthixol 5%
• Low Incidence 5%
• Oral Medication 5%
• Meta-analysis 5%
• Postmarketing 5%
• Risk of Death 5%
• Safety Concerns 5%
• Subgroup Analysis 5%

Neuroscience

• Typical Antipsychotic 100%
• Meta-Analysis 100%
• Randomized Controlled Trial 100%
• Placebo 75%
• Risperidone 25%
• Aripiprazole 25%
• Olanzapine 25%
• Paliperidone 25%
• Fluphenazine 25%
• Vigilance 12%
• Haloperidol 12%
• Zuclopenthixol 12%

Agricultural and Biological Sciences

• Meta-Analysis 100%
• Systematic Review 100%
• Placebo 100%
• Fluphenazine 33%
• Olanzapine 33%
• Paliperidone 33%
• Zuclopenthixol 16%